Published in Epidemiol Infect on July 30, 2007
An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia. BMC Infect Dis (2012) 1.02
Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688. J Clin Microbiol (2012) 0.79
Bacterial Meningitis after Cochlear Implantation among Children without Polyvalent Conjugate Vaccine: A Brief Report of an Iranian Cohort Study on 371 Cases. Int J Prev Med (2014) 0.75
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
Meningococcal disease. N Engl J Med (2001) 8.50
Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med (1997) 5.73
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2005) 4.15
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun (1992) 4.02
[CEREBROSPINAL MENINGITIS IN AFRICA]. Bull World Health Organ (1963) 3.12
WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov (2004) 3.10
A review of vaccine research and development: meningococcal disease. Vaccine (2006) 2.64
Population-based analysis of meningococcal disease mortality in the United States: 1990-2002. Pediatr Infect Dis J (2006) 1.65
Use of variable-number tandem repeats to examine genetic diversity of Neisseria meningitidis. J Clin Microbiol (2005) 1.44
Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR CDC Surveill Summ (1993) 1.25
The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine (2005) 1.17
Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk? Arch Dis Child (2004) 1.16
Case fatality rates for meningococcal disease in an English population, 1963-98: database study. BMJ (2003) 1.14
The incidence and mortality for meningococcal disease associated with area deprivation: an ecological study of hospital episode statistics. Arch Dis Child (2004) 1.10
Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ (2004) 1.08
From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease. Vaccine (2005) 1.07
Forty years of meningococcal disease in Israel: 1951-1990. Clin Infect Dis (1993) 1.04
Meningococcal disease and social deprivation: a small area geographical study in Gwent, UK. Epidemiol Infect (2003) 1.01
Towards an improved serogroup B Neisseria meningitidis vaccine. Expert Opin Biol Ther (2005) 1.01
First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin. Infection (1994) 0.94
The meningococcus tamed? Arch Dis Child (2002) 0.92
Diagnosis and management of meningococcal disease: the need for centralized care. FEMS Microbiol Rev (2007) 0.91
Geographic correlation between deprivation and risk of meningococcal disease: an ecological study. BMC Public Health (2004) 0.91
Risk factors for invasive disease among children in Spain. J Infect (2004) 0.91
The evolving epidemiology of invasive meningococcal disease: a two-year prospective, population-based study in children in the area of Athens. FEMS Immunol Med Microbiol (2003) 0.90
Ascertainment of meningococcal disease in Europe. Euro Surveill (2005) 0.89
Crowding as a risk factor of meningococcal disease in Danish preschool children: a nationwide population-based case-control study. Scand J Infect Dis (2004) 0.88
Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002. Epidemiol Infect (2006) 0.84
Space-time cluster analysis of invasive meningococcal disease. Emerg Infect Dis (2004) 0.84
Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village. Eur J Clin Microbiol Infect Dis (1998) 0.83
The control of meningococcal disease. Med J Aust (2002) 0.80
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst (1997) 4.32
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92
Deficiency of C3 inactivator in man. J Immunol (1971) 2.86
Ras/Rap effector specificity determined by charge reversal. Nat Struct Biol (1996) 2.52
Reduction of transmission of shigellosis by control of houseflies (Musca domestica) Lancet (1991) 2.30
Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. J Infect Dis (1988) 2.14
Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med (1970) 2.08
The interaction between human monocytes and red cells. Specificity for IgG subclasses and IgG fragments. J Exp Med (1970) 2.05
Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet (1997) 1.94
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol (2001) 1.87
Benign metastasizing leiomyoma: clinical, imaging, and pathologic correlation. AJR Am J Roentgenol (2001) 1.81
The interaction between human monocytes and red cells. Binding characteristics. J Exp Med (1970) 1.77
Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. J Clin Microbiol (1991) 1.73
Aquarium-borne Mycobacterium marinum skin infection. Report of a case and review of the literature. Arch Dermatol (1986) 1.71
Prostatic abscess in the antibiotic era. Rev Infect Dis (1988) 1.67
Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections. J Clin Microbiol (1989) 1.58
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. J Clin Oncol (1997) 1.56
Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol (2001) 1.52
The changing panorama of bacterial enteric infections. Epidemiol Infect (2009) 1.46
Evaluation of recurrent thrombosis and hypercoagulability. Am Fam Physician (1997) 1.40
Enterobacter sakazakii infection in the newborn. Acta Paediatr (2001) 1.38
Thermodynamic and kinetic characterization of the interaction between the Ras binding domain of AF6 and members of the Ras subfamily. J Biol Chem (1999) 1.36
Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25. J Clin Oncol (1999) 1.36
School closure may be effective in reducing transmission of respiratory viruses in the community. Epidemiol Infect (2009) 1.36
Severe neonatal citrullinaemia. Arch Dis Child (1974) 1.31
Four decades of shigellosis in Israel: epidemiology of a growing public health problem. Rev Infect Dis (1991) 1.26
Light-in-flight recording by holography. Opt Lett (1978) 1.21
Two different zinc sites in bovine 5-aminolevulinate dehydratase distinguished by extended X-ray absorption fine structure. Biochemistry (1990) 1.16
Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide. J Infect Dis (1992) 1.15
Detection and treatment of brucellosis by screening a population at risk. Pediatr Infect Dis J (1991) 1.15
Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots. J Wound Care (2007) 1.15
Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis. Lancet (1993) 1.12
Design and application of a core genome multilocus sequence typing scheme for investigation of Legionnaires' disease incidents. Euro Surveill (2015) 1.11
Sensitive and specific detection of Xanthomonas campestris pv. pelargonii with DNA primers and probes identified by random amplified polymorphic DNA analysis. Appl Environ Microbiol (1994) 1.10
The IgG subclasses of red cell antibodies and relationship to monocyte binding. Blood (1972) 1.07
New biodegradable polymers for injectable drug delivery systems. J Control Release (1999) 1.07
Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res (1986) 1.07
Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill (2009) 1.06
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection. Clin Microbiol Infect (2006) 1.04
Sulindac sulfide inhibits Ras signaling. Oncogene (1998) 1.04
Saksenaea vasiformis infection in a burn wound. J Med Vet Mycol (1989) 1.04
An outbreak of measles in an ultra-orthodox Jewish community in Jerusalem, Israel, 2007--an in-depth report. Euro Surveill (2008) 1.03
Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology (1997) 1.01
Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem. Epidemiol Infect (2007) 1.01
Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill (2012) 1.00
Cryptococcus neoformans vertebral osteomyelitis. J Med Vet Mycol (1994) 0.96
Convenience store robberies in selected metropolitan areas. Risk factors for employee injury. J Occup Environ Med (1997) 0.95
The role of bougienage in the management of achalasia--the need for reappraisal. Gastrointest Endosc (1982) 0.95
Pseudomonas stutzeri causing late prosthetic valve endocarditis. J R Soc Med (1987) 0.95
Post-transfusion purpura revisted. N Engl J Med (1977) 0.95
Pentazocine and agranulocytosis. Ann Intern Med (1980) 0.95
Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes. Oncogene (2000) 0.94
First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin. Infection (1994) 0.94
Grb7 expression and cellular migration in chronic lymphocytic leukemia: a comparative study of early and advanced stage disease. Leukemia (2004) 0.94
Elimination of symbiotic Aeromonas spp. from the intestinal tract of the medicinal leech, Hirudo medicinalis, using ciprofloxacin feeding. Clin Microbiol Infect (2009) 0.93
Salmonella enterica serotype Virchow: epidemiology, resistance patterns and molecular characterisation of an invasive Salmonella serotype in Israel. Clin Microbiol Infect (2006) 0.93
Discrimination of amino acids mediating Ras binding from noninteracting residues affecting raf activation by double mutant analysis. J Biol Chem (1997) 0.92
Effect of prophylactic antibiotics in radical head and neck surgery. Laryngoscope (1979) 0.92
Culture-based methods for detection and identification of Streptococcus agalactiae in pregnant women--what are we missing? Eur J Clin Microbiol Infect Dis (2007) 0.90
The genes involved in cytokinin biosynthesis in Erwinia herbicola pv. gypsophilae: characterization and role in gall formation. J Bacteriol (1995) 0.90
Glucocorticoid treatment does not improve neurological recovery following cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. JAMA (1990) 0.90
A prospective epidemiologic study of shigellosis in the Israel Defense Forces: implications for the use of shigella vaccines. Isr J Med Sci (1987) 0.89
Domain shuffling as a tool for investigation of protein function: substitution of the cysteine-rich region of Raf kinase and PKC eta for that of yeast Pkc1p. J Mol Biol (2001) 0.89
Rapid screening of urine for bacteria and cells by using a catalase reagent. J Clin Microbiol (1990) 0.89
Gastrointestinal necrosis in acute leukemia: a complication of induction therapy. Cancer Invest (1983) 0.89
Increasing incidence of gonorrhea in Israel associated with countrywide dissemination of a ciprofloxacin-resistant strain. Eur J Clin Microbiol Infect Dis (2002) 0.88
M-components. JAMA (1973) 0.88
The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation. Mol Cell Biol (1998) 0.87
Heat-induced hyperventilation. J Appl Physiol (1968) 0.87
Post-transfusion purpura: immunologic aspects and therapy. N Engl J Med (1974) 0.87
Comparative seroepidemiology of diphtheria in six European countries and Israel. Epidemiol Infect (2012) 0.87
Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling. Oncogene (2000) 0.87
Effect of labor and delivery on neonatal polymorphonuclear leukocyte number and function. Am J Perinatol (1992) 0.86
Shigella lipopolysaccharide antibodies in pediatric populations. Pediatr Infect Dis J (1995) 0.86
Placental blood sampling: an aid to the diagnosis of neonatal sepsis. J Perinatol (1998) 0.86
Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions. Rev Infect Dis (1989) 0.84
Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver. Biochem J (2000) 0.84
Who are the children at risk? Lessons learned from measles outbreaks. Epidemiol Infect (2011) 0.84
Enhancement of neonatal neutrophil motility (chemotaxis) with adult fresh frozen plasma. Am J Perinatol (1992) 0.84
Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum Vaccin Immunother (2015) 0.84
Nasal carriage of Staphylococcus aureus: correlation with hormonal status in women. J Infect Dis (1990) 0.84
Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel. J Clin Microbiol (2001) 0.83
IS1327, a new insertion-like element in the pathogenicity-associated plasmid of Erwinia herbicola pv. gypsophilae. Mol Plant Microbe Interact (1996) 0.83
Proteinuria and antibody-coated bacteria in the urine. N Engl J Med (1977) 0.83